Загрузка...
Updating targets for natural killer/T-cell lymphoma immunotherapy
Natural killer/T-cell lymphoma (NKTCL) is a highly invasive subtype of non-Hodgkin lymphoma, typically positive for cytoplasmic CD3, CD56, cytotoxic markers, including granzyme B and TIA1, and Epstein-Barr virus (EBV). The current treatment methods for NKTCL are associated with several drawbacks. Fo...
Сохранить в:
| Опубликовано в: : | Cancer Biol Med |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Compuscript
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7877170/ https://ncbi.nlm.nih.gov/pubmed/33628584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2020.0400 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|